WHO WE HELP
-
Pharmaceutical Manufacturers
-
MedTech
-
Emerging Biopharma
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialties and Patient Organizations
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
MedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover Innovations
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialties and Patient Organizations
Embrace digital innovation in healthcare to make more informed decisions and advance your mission as a data-driven organization.
Explore NowU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
BLOG
"Words Matter: Use Sentiment Analysis to Understand and Improve the Patient Experience
READ MORE
White Paper
Managing Emerging BioPharma OPEX in the New Investment Environment - Part 2
Focus on NCEs/BLAs: Part 2 of 2
May 30, 2025
This is the second paper in our 2-part analysis on managing operating expenses in the new investment environment. In Part 1, our research focused on the traits of successful products launched by emerging biopharma companies (EBP) under the 505(b)(2) regulatory pathway. This analysis focused on financial metrics to measure success, mainly cumulative breakeven, which compared total lifecycle commercial spend against total net revenue.
In Part 2 of our analysis, we shifted our focus to EBP products launched as new chemical entities (NCEs) and Biologics License Applications (BLAs). And, while we have applied the same methodology to measure financial success, we expanded our scope to also incorporate insights into the commercial strategies behind the finances of these products. Download the white paper now to read the full analysis.
Related solutions
Emerging Biopharma
​Flexible solutions. Responsive teams. Data-driven insights.